# FDA 483 - Michael D. Greenwood, MD - April 11, 2025

Source: https://www.keypedia.com/records/483/michael-d-greenwood-md/1ebe63d4-4d90-4d60-b8bf-cf6adc560d52

> FDA 483 for Michael D. Greenwood, MD on April 11, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Michael D. Greenwood, MD
- Inspection Date: 2025-04-11
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: Michael D. Greenwood, MD, a clinical investigator in West Fargo, ND, was cited for failing to conduct an investigation according to the signed agreement and investigational plan. Specifically, two serious adverse events (SAEs) were reported late and not recorded in the electronic data system via eCRFs. This indicates issues with adverse event reporting and data management in clinical trial conduct.

## Related Officers

- [Mildred J. Tures](https://www.keypedia.com/people/mildred-j-tures/c21df23d-580f-4cdc-94a1-194d981e41be)

Company: https://www.keypedia.com/companies/michael-d-greenwood-md/d2b1fd29-a134-431a-b0b8-73467ea7f0ca

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d